Study | Number of Patients | BMI (kg/m2) at Bariatric Surgery (Mean and standard deviation, except as indicated) | BMI at Last Follow-up (kg/m2) (Mean and standard deviation, except as indicated) | Waitlisted (%) | Transplanted (%) | Clinical Improvement Precluding Need for Listing | Months from Bariatric Surgery to Transplant (Mean and standard deviation, except as indicated) | Months of Follow- up After Bariatric Surgery (Mean and standard deviation, except as indicated) |
---|---|---|---|---|---|---|---|---|
Heart Failure | ||||||||
Amro | 1 | 50 | 44 | NR | NR | NR | NR | 6 |
Caceres | 1 | 37.4 | 29 | 1 (100%) | 1 (100%) | NR | 10 | 22 |
Chaudhry | 6 | 47.6 (SD 3.0)* | NR* | 4 (66.7%) | 0 (0%) | 1 of 6 | NR | median 22 (range 12–70)* |
DeNino | 1 | 50 | 30.4 | 1 (100%) | 1 (100%) | NR | 13 | 16 |
Gill | 2 | 46.6, 43.7 | 34.7, 38.5 | 0 (0%) | 0 (0%) | NR | NR | 5, 14 |
Greene | 3 | 52.3 (SD 2.5) | 29.7 (SD 3.2) | 2 (66.7%) | 2 (66.7%) | 0 of 3 | 17, 24 | 43.7 (SD 12.0) |
Hawkins | 11 | mean 45.2 (range 39–58)* | mean 33.1 (range 26–39)* | 7 (63.6%) | 4 (36.4%) | NR | median 12 (range 5–44)* | median 12 (range 6–39)* |
Jeng | 1 | 40 | 32 | 1 (100%) | 1 (100%) | NR | 7 | 71 |
Lim | 7 | 43.3 (SD 5.0) | 32.4 (SD 4.2) | 4 (57.1%) | 2 (28.6%) | 3 of 7 | NR | 21.7 (SD 16.5) |
Lockard | 2 | 48.8, 52.2 | 38.6, 40.8 | 1 (50.0%) ^ | 1 (50.0%) | NR | 18 | NR, 24 |
McCloskey | 14 | 50.8 (SD 7.6) | 37.1 (SD 7.2) | 2 (14.3%) | 2 (14.3%) | NR | 6, 8 | 6.7 (SD 2.2) |
Punchai | 7 | 44.3 (SD 6.4) | 35.0 (SD 7.9) | 3 (42.8%) | 3 (42.8%) | NR | 17.7 (SD 5.7) | 20.6 (SD 24.2) |
Ramani | 12 | 53 (SD 7.0) | 47 (SD 4.0) | 2 (16.7%) | 1 (8.3%) | NR | NR | NR |
Ristow | 2 | 43, 56 | 23, 37 | 2 (100%) | 0 (0%) | 2 of 2 | NR | 24, 24 |
Saeed | 1 | 41.6 | 41 | 1 (100%) | 1 (100%) | 0 of 1 | 13 | 21 |
Samaras | 2 | 42, 40 | 31.2, 34.7 | 1 (50.0%) | 1 (50.0%) | 1 of 2 | 13 | 12, 13 |
Shah | 4 | 49.2(SD 5.9) | 5.5 (4.6) | 2 (50.0%) | 1 (25.0%) | NR | 9 | 7.0 (SD 2.3) |
Taylor | 1 | 48.6 | 28.5 | 1 (100%) | 1 (100%) | NR | 19 | 25 |
Wikiel | 4 | 47.7 (SD 4.4) | 35.3 (SD 4.1) | 3 (75.0%) | 3 (75.0%) | NR | 13.3 (SD 4.7) | 48.5 (SD 42.1) |
TOTAL | 82 | 48.4 (SD 6.6) | 37.1 (SD 5.8) | 33 (40.2%) | 24 (29.3%) | 7 (8.5%) | 13.9 (SD 5.4) | 21.8 (SD 22.2) |
End-Stage Lung Disease | ||||||||
Ardila-Gatas | 25 | median 39 (IQR 37–44)* | median 30 (IQR 25–36)* | 6 (24%) | 1 (4%) | 3 (12%) | 88 | NR |
Martin | 1 | 37 | <30* | 0 (0%)** | 0 (0%)** | 1 (100%) | N/A | 5 |
Takata | 2 | 46 (4.5) | NR* | 2 (100%) | 1 (50%) | 0 (0%) | NR | 12.5 (SD 0.7) |
TOTAL | 28 | 42.7 (5.4) | -- | 8 (28.6%) | 2 (7%) | 4 (14.3%) | 88 | 10 (SD 4.3) |
Cirrhosis | ||||||||
Reached BMI<40 kg/m2 by 6 Months | Reached BMI<40 kg/m2 by 12 Months | |||||||
Garcia-Sesma | 8 | 6 (of 7; 85.7% | 6 (75.0%) | 2 (25.0%) | 2 (25.0%) | -- | 7, 8 | 33.2 (SD 23.6 |
Sharpton | 32 | 13 (of 22; 59.1% | 20 (62.5%) | 21 (65.6%)* | 14 (43.7%) | 9 (28.1%) | median 22 (IQR 1488)** | -- |
Taneja | 1 | 1 (100%) | 1 (100%) | 1 (100%) | 1 (100%) | 0 (0%) | 12 | 12 |
TOTAL | 41 | 20 (of 30; 66.7%) | 27 (65.8%) | 24 (58.5%) | 17 (41.5%) | 9 (of 33; 27.3%) | 9.0 (SD 2.6) | 30.9 (23.2) |
Chronic Kidney Disease | ||||||||
BMI (kg/m2) at Bariatric Surgery | BMI (kg/m2) at Last Follow-up | |||||||
Adani | 3 | NR* | NR* | 2 (67%) | 2 (67%) | -- | NR* | NR* |
Al Sabah | 1 | 42 | 31.5 | 1 (100%) | 1 (100%) | -- | 29 | 6 |
Al Bahri | 16 | 47.5 (SD 7.5) | 30.9 (6.4) | 4 (25%) | 9 (56%) | -- | 53.2 (SD 16.3) | 42.0 (32.8) |
Alexander | 41 | 48 (SD NR)* | NR* | 9 (22%) | 9 (22%) | -- | NR | NR* |
Buch | 1 | NR* | NR* | 1 (100%) | 1 (100%) | -- | 24 | NR* |
Carandina | 9 | 47.0 (SD 7.1) | 33.6 (7.4) | 1 (11%) | 5 (56%) | -- | 21 | 15.7 (10.6) |
Contreras-Villamizar | 1 | 42 | 28.6 | 0 (0%) | 1 (100%) | -- | No transplant | 12 |
Jamal | 21 | 47.1 (SD 5.5) | 35.3 (8.4) | 2 (10%) | 18 (86%) | -- | NR | 27.6 (22) |
Kienzl-Wagner | 8 | 38.8 (SD 3.8) | 30.7 (6.0) | 7 (88%) | 8 (100%) | -- | 17.6 (SD 10.5) | 38.4 (16.8) |
Kim | 100 | 43.4 (SD 5.9) | 36.9 (5.7) | 19 (19%) | 19 (19%) | -- | NR | NR* |
Koshy | 3 | 40.7 (SD 4.9) | 37.2 (1.9) | 3 (100%) | 3 (100%) | -- | NR | 13.7 (1.2) |
Lin | 6 | NRBO* | NRBO* | 1 (17%) | 6 (100%) | -- | NRBO | NR* |
MacLaughlin | 9 | median 44.2* | median 34.7 (range 29.2 – 38.8)* | 0 (0%) | 3 (33%) | -- | No transplant | 12* |
Marszalek | 1 | 41.5 | 29 | 1 (100%) | 1 (100%) | -- | 10 | 10 |
Newcombe | 3 | 44.6 (SD 5.5) | 33.8 (5.0) | 3 (100%) | 3 (100%) | -- | 16.3 (SD 10.2) | 16.3 (8.3) |
Proczko | 3 | 39.9 (SD 2.1) | 31.1 (2.4) | 1 (33%) | 3 (100%) | -- | 3 | 3 (0) |
Takata | 7 | 49.9 (SD 5.7) | NR* | 0 (0%) | 7 (100%) | -- | No transplant | NR* |
Thomas | 31 | 43.5 (SD 0.7) | 28.1 (SD 0.8) | 14 (67%) | 25 (81%) | -- | median 33* | NR* |
Yemeni | 24 | 41.5 (SD 0.8) | 29 (SD 1.3) | 16 (67%) | 21 (88%) | -- | 18 (1 – 51.6)* | 47.0 (6.5) |
TOTAL | 288 | 44.0 (5.5) | 33.7 (5.3) | 85 (30%) | 145 (50%) | -- | 24.8 (14.2) | 32.9 (21.4) |